Managing corticosteroid induced osteoporosis in medical outpatients

Journal of the Royal College of Physicians of London

Volumn 31, Issue 2, 1997, Pages 158-161

  Bell, Rebecca ^b   Carr, Alison ^b   Thompson, Paul ^a  

^a POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCITRIOL; CORTICOSTEROID; PREDNISOLONE;

ADULT; AGED; ARTHRITIS; ARTICLE; BONE DENSITY; BONE MINERAL; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HORMONAL THERAPY; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSTRUCTIVE AIRWAY DISEASE; OSTEOPOROSIS; OUTPATIENT; RHEUMATOLOGY;

AGED; ANTI-INFLAMMATORY AGENTS; BONE DENSITY; CLINICAL PROTOCOLS; DENSITOMETRY, X-RAY; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PREDNISOLONE;

EID: 0030913983     PISSN: 00358819     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Fitzpatrick LA. Glucocorticoid induced osteoporosis. In: Markus R (ed). Osteoporosis. Boston: Blakewell Scientific Publications, 1994: 202-26.
2. Dykman TR, Gluck OS, Murphy WA, Hahn TJ, Hahn BH. Evaluation of factors associated with glucocorticoid induced osteopenia in rheumatoid arthritis. Arthritis Rheum 1985;28:361-8.
3. Lukert BP, Johnson TD, Robinson RG. Estrogen and progesterone replacement therapy reduces glucocorticoid induced bone loss. J Bone Min Res 1990;7:1063-9.
4. Reid IR, King AR, Alexander CJ, Ibbertson HK. Prevention of steroid induced osteoporosis with APD. Lancet 1988;i:143-6.
5. Adachi JD, Cranney A, Goldsmith CH, Benson WG, et al. Intermittent therapy with etidronate in the prevention of corticosteroid induced bone loss. J Rheumatol 1994;21:1922-6.
6. Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, et al. Prevention of corticosteroid osteoporosis - a comparison of calcium, calcitriol and calcitonin. N Engl J Med 1993;328:1747-52.
7. Assessment of fracture risk and its application for postmenopausal osteoporosis: Report of a WHO study group. WHO Technical Report Series 843. Geneva: WHO, 1994.
8. Eastell R. Management of corticosteroid-induced osteoporosis (review). J Intern Med 1995;237:439-47.
9. Corticosteroid induced osteoporosis - management guidelines. Newsletter of the South West Regional Advisory Board. Professional Communications, 1996.
10. Adinoff AD, Hollister JR. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 1983;309:265-8.
11. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990;112: 352-64.
12. Wolfe F, Furst D, Lane N, Anderson J, Hawley DJ. Substantial increases in important adverse events follow low dose prednisone therapy of the rheumatoid arthritis. Arthritis Rheum 1995;38(suppl):S312.
13. Peat ID, Healy S, Reid DM, Ralston S. Steroid induced osteoporosis: an opportunity for prevention? Ann Rheum Dis 1995;54:66-8.
14. Walsh LJ, Wong CA, Pringle M, Tattersfield AE. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. Br Med J 1996;313:344-6.